ArticleTherapeutic drug monitoring2026
In vitro Study of the Effects of Acetylcysteine on the International Normalized Ratio Over Time.
Article in Therapeutic drug monitoring, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with paracetamol poisoning are treated with acetylcysteine. In paracetamol-poisoned patients without hepatocellular injury, an increased international normalized ratio (INR) was observed after acetylcysteine administration. Because INR is a marker of liver injury in paracetamol poisoning, assessing the magnitude of the effect of acetylcysteine treatment on INR is crucial. This in vitro study aimed to quantify the effects of clinically relevant concentrations of acetylcysteine on INR over time.
methodsAcetylcysteine (0-500 mg/L) in Omniplasma (pooled plasma) or citrate plasma from 6 healthy subjects was incubated at 37°C for up to 24 or 6 hours, respectively. Combined with acetylcysteine, the effects of paracetamol (0-200 mg/L), incubation temperature (37, 20, and 4°C), and tube size (15 and 2.5 mL) were investigated. Samples were drawn frequently and analyzed for INR. Citrate plasma from healthy subjects was used to assess interindividual variability. Data were analyzed using a generalized linear mixed model.
resultsAt 37°C, every mmol/L (equals 163 mg/L) of acetylcysteine increased the INR with 0.039 (99% confidence interval [CI] 0.032-0.046, P < 0.0001), whereas every mmol/L (equals 151 mg/L) of paracetamol increased the INR with 0.028 (99% CI 0.013-0.044, P < 0.001). Independent of acetylcysteine and paracetamol, every hour of incubation at 37°C increased the INR by 0.012 (99% CI 0.011-0.014, P < 0.0001). Incubating 100, 200, and 500 mg/L acetylcysteine in plasma from healthy subjects at 37°C showed large interindividual variability in INR from 0.058 (99% CI 0.029-0.086, P < 0.001) to 0.173 (99% CI 0.131-0.216, P < 0.0001).
conclusionsThis in vitro study showed a clinically significant effect of increasing acetylcysteine concentrations on INR over time at 37°C in pooled plasma. Additionally, a large interindividual variability was observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.